Page last updated: 2024-10-30

labetalol and Uveal Diseases

labetalol has been researched along with Uveal Diseases in 2 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Uveal Diseases: Diseases of the uvea.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schiavo, DM1
Sinha, DP1
Black, HE1
Arthaud, L1
Massa, T1
Murphy, BF1
Szot, RJ1
Schwartz, E1
Murray, DL1
Podos, SM1
Wei, C1
Leopold, IH1

Other Studies

2 other studies available for labetalol and Uveal Diseases

ArticleYear
Tapetal changes in beagle dogs. I. Ocular changes after oral administration of a beta-adrenergic blocking agent--SCH 19927.
    Toxicology and applied pharmacology, 1984, Volume: 72, Issue:2

    Topics: Animals; Choroid; Dogs; Ethanolamines; Female; Labetalol; Male; Ophthalmoscopy; Optic Disk; Uveal Di

1984
Ocular effects in normal rabbits of topically applied labetalol: a combined alpha- and beta-adrenergic antagonist.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1979, Volume: 97, Issue:4

    Topics: Animals; Aqueous Humor; Dose-Response Relationship, Drug; Ethanolamines; Eye; Female; Intraocular Pr

1979